Abstract:Long noncoding RNAs (lncRNAs) are essential transcripts with critical roles in tumor initiation and malignant progression. In the present study, through analysis of whole-transcriptome profiles, we showed that MIR22 host gene (MIR22HG), the primary microRNA of miR-22, ranked among the most overexpressed lncRNAs in glioblastoma (GBM). Herein, our study aims to elucidate the biological functions of MIR22HG and therapeutic potency of MIR22HG targeted inhibition in GBM. We characterized the expression pattern of MIR22HG/miR-22 by bioinformatics analysis and by in situ hybridization (ISH) in GBMs. We further determined whether genetic targeting of MIR22HG affected oncogenic functions of primary GBM cells in vitro and in vivo. A co-culture model where brain organoids are co-cultured with GBM spheroids were utilized for the invasion assessment. Finally, based on the three-dimensional structure of the pre-miR-22, we performed virtual screening strategy to disclose a novel inhibitor of the MIR22HG/miR-22 axis. We showed that MIR22HG/miR-22 was highly expressed in GBM, especially in isocitrate dehydrogenase 1/2 (IDH1/2) wild-type tumors. Specially, MIR22HG/miR-22 was preferentially expressed in glioblastoma stem cells (GSCs) compared to normal neural stem cell (NSCs). Analysis of intra-tumoral transcriptional heterogeneity showed that MIR22HG was higher in the infiltrating region compared to the tumor center. In functional assays, silencing MIR22HG attenuated aggressive phenotypes in GBM cells, including invasion, self-renewal and in vivo tumor growth via suppressing the production of miR-22-3p and miR-22-5p. Using a luciferase reporter assay, we further confirmed that two inhibitors of the Wnt/β-catenin pathway, SFRP2 and PCDH15, were direct targets of miR-22-3p and miR-22-5p. Finally, we identified a specific inhibitor termed AC1L6JTK, which blocks the ability of Dicer to process pre-miR-22 to mature miR-22, thus exerting therapeutic efficacy on GBMs. Our findings show that the MIR22HG/miR-22 axis is a novel biomarker as well as a therapeutic target in GBM.

MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Downregulation of Long Non-Coding RNA MR4435-2HG Suppresses Breast Cancer Progression Via the Wnt/β-catenin Signaling Pathway.

Lncrna MIR22HG-Derived Mir-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.

Tumor Suppressor Mir-22 Suppresses Lung Cancer Cell Progression Through Post-Transcriptional Regulation of Erbb3

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers

LncRNA MIR22HG Inhibits Growth, Migration and Invasion Through Regulating the Mir‐10a‐5p/ncor2 Axis in Hepatocellular Carcinoma Cells

Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer.

Interfering with Long Non-Coding RNA MIR22HG Processing Inhibits Glioblastoma Progression Through Suppression of Wnt/β-catenin Signalling

Mir-135b, Upregulated in Breast Cancer, Promotes Cell Growth and Disrupts the Cell Cycle by Regulating Lats2

Mirna-22 Suppresses Colon Cancer Cell Migration and Invasion by Inhibiting the Expression of T-cell Lymphoma Invasion and Metastasis 1 and Matrix Metalloproteinases 2 and 9.

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.

MiR-22 Down-Regulates the Proto-Oncogene ATP Citrate Lyase to Inhibit the Growth and Metastasis of Breast Cancer.

CSIG-28. LONG NONCODING RNA MIR22 HOST GENE-DERIVED miR-22-3p AND miR-22-5p PROMOTE PROLIFERATION, INVASION AND SELF-RENEWAL IN HUMAN GLIOMAS VIA Wnt/-CATENIN SIGNALING

MIR22HG Regulates Mir-486/Pten Axis in Bladder Cancer to Promote Cell Proliferation.

MiR-218-5p&nbsp;promotes breast cancer progression via LRIG1

Long Non-Coding RNA MIR200CHG Promotes Breast Cancer Proliferation, Invasion, and Drug Resistance by Interacting with and Stabilizing YB-1

MiR-218-5p promotes breast cancer progression via LRIG1

LncRNA MIR17HG Suppresses Breast Cancer Proliferation and Migration as ceRNA to Target FAM135A by Sponging miR-454-3p